Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Lupus Remission Linked to Better Pregnancy Outcomes
October 2026
A prospective study found higher pregnancy complication rates in women with lupus who were not in remission, particularly among high-risk patients.
Read more
19 Oct 2026
Lupus Remission Linked to Better Pregnancy Outcomes
A prospective study found higher pregnancy complication rates in women with lupus who were not in remission, particularly among high-risk patients.
12 Oct 2026
Peresolimab in Rheumatoid Arthritis: Cellular and Proteomic Changes
Peresolimab has been linked to fewer PD-1 high-expressing CD4 T cells and neutrophils, and reduced inflammatory signalling in rheumatoid arthritis.
9 Oct 2026
Plasma Protein Signatures Reveal Damage in Ankylosing Spondylitis
Plasma protein signatures have been associated with high structural damage in ankylosing spondylitis, with potential to complement imaging assessment.
7 Oct 2026
Rituximab Shows No Clear Advantage in SLE Lupus Nephritis
Rituximab, mycophenolate mofetil, and cyclophosphamide strategies have shown no significant differences in 52-week outcomes in SLE with lupus nephritis.
5 Oct 2026
New Insights on Cancer Risks with Rheumatoid Arthritis Drugs
Advanced therapies have not been linked to clearly different cancer risks in patients with rheumatoid arthritis and prior cancer, a new study has shown.
2 Oct 2026
Cognitive Disorders and Dementia More Likely in Sjögren’s Disease
A cohort of 12,731 patients showed that primary Sjögren’s disease is linked to higher risks of cognitive disorders and dementia, supporting clinical attention to cognition across age groups.
30 Sep 2026
Obesity Pharmacotherapy Offers Osteoarthritis Pain Relief, Not Repair
A narrative review has found obesity pharmacotherapy relieves osteoarthritis pain, but evidence of structural joint modification has remained absent.
25 Sep 2026
Alcohol Consumption and Higher Risk of Incident Osteoarthritis
A South Korean cohort study of over 1.2 million adults found alcohol consumption was linked to a dose-dependent rise in osteoarthritis risk.
Loading posts...
1
2
3
…
50
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View